About HTAi Policy Forum
Policy Forum members: log in to access meeting materials
**To access Forum materials, log in using the box in the top-right corner of the page, and then click here.
HTAi Policy Forum: Overview
HTAi’s mission is to support and promote the development, communication, understanding and use of HTA around the world as a scientifically based means of promoting the introduction of effective innovations and the effective use of resources in health care.
The HTAi Policy Forum provides a unique opportunity for senior people from public and private sector organizations using HTA to support decisions or recommendations about product development and coverage to meet one another, members of the HTAi Board, and invited international experts, for strategic discussions about the present state of HTA, its development and implications for health care systems, industry, patients and other stakeholders. The aim of the Forum is to provide an environment where senior people can engage in strategic discussions informed by the perspectives of their different organizations without the constraints associated with discussions of specific products or organizational policies.
Membership in the HTAi Policy Forum is by application. From time to time (typically around April each year) HTAi issues calls for Expressions of Interest in joining the Policy Forum. Final decisions on membership are made by the HTAi Board of Directors on advice from the Policy Forum Committee.
Papers of the HTAi Policy Forum: Free access now available
Each year, the discussions of the HTAi Policy Forum are published in the International Journal of Technology Assessment in Health Care. Free access to these papers is available below, along with links to other Policy Forum grey literature (e.g., background papers).
2015 Background paper - "Improving the effectiveness and efficiency of evidence production for HTA in the light of current trends in drug and device development, health system funding, regulation and HTA"
K. Facey on behalf of the HTAi Policy Forum
"Adaptive Approaches to Licensing, Health Technology Assessment, and Introduction of Drugs and Devices"
D. Husereau, C. Henshall & J. Jivraj on behalf of the HTAi Policy Forum
"Health Technology Assessment, value-based decision making, and innovation"
C. Henshall & T. Schuller on behalf of the HTAi Policy Forum (deliberations of the 2013 meeting) Provisional PDF available ahead of publication.
Background paper: HTA & Value (preparation for the 2013 Policy Forum discussion on HTA & Value).
"Using Health Technology Assessment to Support Optimal Use of Technologies in Current Practice: The Challenge of "Disinvestment""
C. Henshall, T. Schuller, L. Mardhani-Bayne on behalf of the HTAi Policy Forum (deliberations from the 2012 meeting)
"Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities"
C. Henshall, L. Mardhani-Bayne, K. Fronsdal, M. Klemp on behalf of the HTAi Policy Forum (deliberations from the 2011 meeting)
"What principles should govern the use of managed entry agreements?"
M. Klemp, K. Fronsdal, K. Facey on behalf of the HTAi Policy Forum (deliberations from the 2010 meeting)
“HTA to optimize health technology utilization: using implementation initiatives and monitoring processes”
K. Fronsdal, K. Facey, M. Klemp et al. on behalf of the HTAi Policy Forum (deliberations from the 2009 meeting)
"Harmonization of evidence requirements in HTA for reimbursement decision-making"
J. Hutton, P. Trueman, K. Facey on behalf of the HTAi Policy Forum (deliberations from the 2008 meeting)
"Coverage with Evidence Development: an examination of conceptual and policy issues"
J. Hutton, P. Trueman, C. Henshall on behalf of the HTAi Policy Forum (deliberations from the 2007 meeting)
For more information
Policy Forum Member Selection Process (updated October 2015)
Questions? Contact the HTAi Secretariat.